Intelligent Wound Cleansing Apparatus with Adaptive Biomarker Sensing and AI-Driven Optimization

Publication ID: 24-11857746_0010_PTD
Published: November 07, 2025
Category:Future Evolutions & Paradigm Shifts

Legal Citation

pr1or.art Inc., “Intelligent Wound Cleansing Apparatus with Adaptive Biomarker Sensing and AI-Driven Optimization,” Published Technical Disclosure No. 24-11857746_0010_PTD, Published November 07, 2025, available at https://archive.pr1or.art/24-11857746_0010_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,746.

Summary of the Inventive Concept

A next-generation wound cleansing apparatus that integrates bio-sensing, microfluidic analysis, artificial intelligence, and modular design to provide real-time monitoring and adaptive optimization of wound healing, surpassing the limitations of traditional negative pressure wound therapy systems.

Background and Problem Solved

The original patent described a negative pressure wound therapy system for cleansing wounds, but it had limitations in detecting biomarkers, analyzing wound exudate composition, and adapting to individual wound characteristics. The new inventive concept addresses these limitations by incorporating advanced technologies to create a more effective, efficient, and personalized wound healing solution.

Detailed Description of the Inventive Concept

The intelligent wound cleansing apparatus features a bio-sensing module integrated into the conformable wound dressing, which detects biomarkers indicative of wound healing and adjusts cleansing parameters accordingly. The apparatus also includes a microfluidic analyzer embedded in the wound dressing, which analyzes wound exudate composition and adjusts cleansing parameters based on the analysis results. Additionally, the system incorporates artificial intelligence, which predicts optimal cleansing protocols based on machine learning algorithms and adapts to individual wound characteristics. The modular design allows for interchangeable cleansing cartridges, each containing a distinct solid particulate for sequestering specific deleterious materials from wound exudate. Furthermore, the apparatus features a nanofibrous membrane with tunable porosity, which selectively filters out deleterious materials from wound exudate while allowing beneficial materials to pass through.

Novelty and Inventive Step

The new claims introduce a paradigm shift in wound cleansing technology by integrating bio-sensing, microfluidic analysis, artificial intelligence, and modular design. The inventive concept's adaptive optimization of wound healing, real-time monitoring, and personalized approach are novel and non-obvious compared to the original patent's traditional negative pressure wound therapy system.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept could include variations in the bio-sensing module, such as using different biomarkers or sensing technologies. The microfluidic analyzer could be replaced with other analytical techniques, and the artificial intelligence could be trained on different datasets or algorithms. The modular design could be adapted for use with different types of wounds or patient populations, and the nanofibrous membrane could be modified to have different porosity levels or filtering properties.

Potential Commercial Applications and Market

The intelligent wound cleansing apparatus has significant commercial potential in the wound care market, particularly in the treatment of chronic wounds. The apparatus's ability to provide real-time monitoring and adaptive optimization of wound healing could reduce healthcare costs, improve patient outcomes, and increase patient satisfaction. The target industries include wound care clinics, hospitals, and medical device manufacturers.

CPC Classifications

SectionClassGroup
A A61 A61M3/0229
A A61 A61F13/00068
A A61 A61F13/0206
A A61 A61F13/0213
A A61 A61F13/0216
A A61 A61F13/0259
A A61 A61M1/77
A A61 A61M1/81
A A61 A61M1/82
A A61 A61M1/85
A A61 A61M1/915
A A61 A61M1/92
A A61 A61M1/962
A A61 A61M1/985
A A61 A61M3/022
A A61 A61M3/0216
A A61 A61M35/30
A A61 A61F2013/00357
A A61 A61M1/75
A A61 A61M1/772
A A61 A61M1/916
A A61 A61M27/00
A A61 A61M2205/075
A A61 A61M2205/106
A A61 A61M2205/7518
A A61 A61M2205/8206
Y Y10 Y10T29/49826

Field of Art

Medical device engineering, specifically wound care technologies, focusing on negative pressure wound therapy systems, biomedical sensing, and advanced wound dressing technologies

Person of Ordinary Skill (PHOSITA) Profile

A biomedical engineer or medical device designer with expertise in wound care technologies, advanced materials, microfluidics, and biosensing techniques, holding at least a master's degree with 3-5 years of specialized experience in medical device development

Obviousness Rationale

A PHOSITA would recognize that the disclosed intelligent wound cleansing apparatus represents a predictable extension of existing negative pressure wound therapy technologies by integrating known biosensing, microfluidic, and artificial intelligence techniques into a wound dressing framework. The core functional elements of wound protection, exudate management, and healing optimization are consistent with the source patent, with the PTD introducing incremental technological enhancements that would be obvious to implement using standard engineering design approaches.

Obvious Combinations & Variations

Source Patent Element
Wound dressing with backing layer and wound contact layer for negative pressure wound therapy
PTD Variation
Integration of bio-sensing module and microfluidic analyzer into the wound dressing structure
Obviousness Reasoning
Adding sensing and analytical capabilities to medical devices is a known technique in biomedical engineering, representing a predictable application of existing technologies to improve diagnostic capabilities
Source Patent Element
Absorbent material positioned between wound contact and backing layers
PTD Variation
Nanofibrous membrane with tunable porosity for selective material filtration
Obviousness Reasoning
Material science techniques for creating selective membranes are well-established, and a PHOSITA would recognize this as an obvious improvement in controlling wound exudate composition
Source Patent Element
Negative pressure wound therapy system for wound treatment
PTD Variation
Artificial intelligence-driven optimization of cleansing parameters based on machine learning algorithms
Obviousness Reasoning
Applying machine learning to medical device optimization is a known approach, representing a standard design choice for improving treatment personalization and efficacy
Source Patent Element
Wound dressing with vent for excess fluid management
PTD Variation
Modular design with interchangeable cleansing cartridges for targeted material sequestration
Obviousness Reasoning
Modular medical device design is a common engineering approach, and a PHOSITA would find the concept of specialized cartridges for targeted wound treatment an obvious extension of existing fluid management techniques
Source Patent Element
Basic wound dressing with adhesive layer for skin attachment
PTD Variation
Real-time biomarker detection and dynamic parameter adjustment
Obviousness Reasoning
Integrating real-time monitoring and adaptive response is a predictable technological progression in medical device design, representing an obvious enhancement to existing wound care technologies
35 U.S.C. § 103 Summary: Based on the teachings of US Patent 11857746 and the disclosed technological variations, a person having ordinary skill in the art would find the claimed innovations in intelligent wound cleansing apparatus to be obvious variations of existing negative pressure wound therapy technologies. The incremental advancements in biosensing, microfluidic analysis, and artificial intelligence optimization represent predictable extensions of known medical device engineering techniques, thereby rendering potential patent claims obvious and unpatentable under 35 U.S.C. Section 103.

Original Patent Information

Patent NumberUS 11,857,746
TitleWound cleansing apparatus in-situ
Assignee(s)Smith & Nephew PLC